Cytologic smears of peritoneal surfaces as a sampling technique in epithelial ovarian carcinoma

• Published in: Obstetrics and gynecology (New York. 1953) Vol. 75; no. 1; p. 102
• Main Authors: Jadhon, M E, Morgan, M A, Kelsten, M L, Carlson, Jr, J A, Mikuta, J J
• Format: Journal Article
• Language: English
• Published: United States 01-01-1990
• Subjects: Ascitic Fluid - pathology; Biopsy; Female; Humans; Neoplasm Staging; Ovarian Neoplasms - pathology; Peritoneal Neoplasms - diagnosis; Peritoneal Neoplasms - secondary; Peritoneum - pathology; Specimen Handling - methods
• ISSN: 0029-7844

Ovarian carcinoma disseminates primarily through the shedding of cells into the peritoneal cavity and subsequent implantation onto peritoneal surfaces. Accurate evaluation of the extent of disease is important both at initial surgical evaluation for staging and at second-look operations to determine the necessity of further therapy. Techniques used for such assessment include node sampling, peritoneal washings, and random biopsies of peritoneal surfaces. Although random biopsies are used by some, others have found them to be of negligible value in the absence of gross disease. The use of cytologic smears of peritoneal surfaces offers a simple method by which cells from a large surface area may be evaluated, and uses equipment readily available to the gynecologist. We compared results of 125 cytologic smears with washings and biopsy specimens obtained during 33 laparotomies for ovarian carcinoma. Cytologic smears identified disease in 48 of 125 sites, whereas biopsy identified only 29 areas of disease. Thirteen of the positive Papanicolaou smears were obtained from clinically disease-free areas. Although the cytologic evaluation of the parietal peritoneal surfaces was more frequently positive than were biopsy specimens, each method identified disease in 16 patients when paired with standard techniques of examination and washing. We conclude that the peritoneal cytologic smear offers an alternative method of further evaluating the extent of disease, particularly when no gross evidence of extraovarian disease is detected.